Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
10/02/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2.6k | $0.00 | $0 | | 10/02/2023 |
07/05/2023 | Alphabet Inc. | GOOG | Grant | | 2.8k | $0.00 | $0 | | 07/05/2023 |
07/03/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2.5k | $0.00 | $0 | | 07/03/2023 |
04/03/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2.7k | $0.00 | $0 | | 04/03/2023 |
01/03/2023 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2.5k | $0.00 | $0 | | 01/03/2023 |
10/03/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1.7k | $0.00 | $0 | | 10/03/2022 |
07/01/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2.2k | $0.00 | $0 | | 07/01/2022 |
06/14/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Stock Option (right to buy) | 36.3k | $6.20 | $225k | | 06/14/2022 |
06/14/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 18.1k | $0.00 | $0 | | 06/14/2022 |
04/01/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 2.4k | $0.00 | $0 | | 04/01/2022 |
01/03/2022 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 1k | $0.00 | $0 | | 01/03/2022 |
10/01/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 858 | $0.00 | $0 | | 10/01/2021 |
07/01/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Class A Common Stock | 521 | $0.00 | $0 | | 07/01/2021 |
04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Class A Common Stock | 6.2k | $0.00 | $0 | | 04/20/2021 |
04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Stock Option (Right to Buy) | 12.5k | $18.00 | $225k | | 04/20/2021 |
04/20/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Conversion | Stock Option (Right to Buy) | 525k | $2.22 | $1.2M | | 04/20/2021 |
04/16/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | | 6.2k | $0.00 | $0 | | 04/15/2021 |
04/15/2021 | RECURSION PHARMACEUTICALS, INC. | RXRX | Grant | Stock Option (Right to Buy) | 12.5k | $18.00 | $225k | | 04/15/2021 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 500 | $260.43 | $130.2k | See footnote | 02/07/2018 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 500 | $259.26 | $129.6k | See footnote | 02/07/2018 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 540 | $257.39 | $139k | See footnote | 02/07/2018 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 300 | $261.27 | $78.4k | | 02/07/2018 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 2.7k | $260.44 | $691.7k | | 02/07/2018 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 4k | $259.44 | $1M | | 02/07/2018 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 1.8k | $258.38 | $465.1k | | 02/07/2018 |
02/07/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 1.6k | $257.46 | $405.5k | | 02/07/2018 |
01/31/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 1.5k | $267.01 | $412k | | 01/31/2018 |
01/31/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 2.1k | $268.14 | $565.2k | | 01/31/2018 |
01/31/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 3.5k | $268.92 | $934.2k | | 01/31/2018 |
01/31/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 3.2k | $269.72 | $853.4k | | 01/31/2018 |
01/31/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 200 | $266.96 | $53.4k | See footnote | 01/31/2018 |
01/31/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 540 | $268.45 | $145k | See footnote | 01/31/2018 |
01/31/2018 | GOLDMAN SACHS GROUP INC | GS | Sale | Common Stock, par value $0.01 per share | 800 | $269.53 | $215.6k | See footnote | 01/31/2018 |
12/28/2017 | GOLDMAN SACHS GROUP INC | GS | Exercise | Restricted Stock Units | 58.1k | $0.00 | $0 | | 12/28/2017 |
12/28/2017 | GOLDMAN SACHS GROUP INC | GS | Payment of Exercise | Common Stock, par value $0.01 per share | 32.4k | $255.95 | $8.3M | | 12/28/2017 |